Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS
暂无分享,去创建一个
P. Huppke | E. Waubant | L. Krupp | T. Chitnis | M. Merschhemke | J. Gärtner | B. Banwell | K. Deiva | T. Stites | G. Pearce